[HTML][HTML] Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental …

S Srivastava, JA Love-Nichols, KA Dies… - Genetics in …, 2019 - Elsevier
Abstract Purpose For neurodevelopmental disorders (NDDs), etiological evaluation can be a
diagnostic odyssey involving numerous genetic tests, underscoring the need to develop a …

Genetic testing in neurodevelopmental disorders

JM Savatt, SM Myers - Frontiers in Pediatrics, 2021 - frontiersin.org
Neurodevelopmental disorders are the most prevalent chronic medical conditions
encountered in pediatric primary care. In addition to identifying appropriate descriptive …

Beyond the exome: what's next in diagnostic testing for Mendelian conditions

MH Wojcik, CM Reuter, S Marwaha… - The American Journal of …, 2023 - cell.com
Despite advances in clinical genetic testing, including the introduction of exome sequencing
(ES), more than 50% of individuals with a suspected Mendelian condition lack a precise …

The clinical utility of exome and genome sequencing across clinical indications: a systematic review

S Shickh, C Mighton, E Uleryk, P Pechlivanoglou… - Human genetics, 2021 - Springer
Exome sequencing and genome sequencing have the potential to improve clinical utility for
patients undergoing genetic investigations. However, evidence of clinical utility is limited to …

Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta‐analysis

A Stefanski, Y Calle‐López, C Leu, E Pérez‐Palma… - …, 2021 - Wiley Online Library
Objective Clinical genetic sequencing is frequently utilized to diagnose individuals with
neurodevelopmental disorders (NDDs). Here we perform a meta‐analysis and systematic …

The responsibility to recontact research participants after reinterpretation of genetic and genomic research results

Y Bombard, KB Brothers, S Fitzgerald-Butt… - The American Journal of …, 2019 - cell.com
The evidence base supporting genetic and genomic sequence-variant interpretations is
continuously evolving. An inherent consequence is that a variant's clinical significance might …

Evaluating systematic reanalysis of clinical genomic data in rare disease from single center experience and literature review

NB Tan, R Stapleton, Z Stark… - Molecular genetics & …, 2020 - Wiley Online Library
Background Our primary aim was to evaluate the systematic reanalysis of singleton exome
sequencing (ES) data for unsolved cases referred for any indication. A secondary objective …

A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis

JLF Fung, MHC Yu, S Huang, CCY Chung… - NPJ genomic …, 2020 - nature.com
Exome sequencing (ES) has become one of the important diagnostic tools in clinical
genetics with a reported diagnostic rate of 25–58%. Many studies have illustrated the …

[HTML][HTML] Re-analysis of genomic data: an overview of the mechanisms and complexities of clinical adoption

AJ Robertson, NB Tan, AB Spurdle… - Genetics in …, 2022 - Elsevier
Re-analyzing genomic information from a patient suspected of having an underlying genetic
condition can improve the diagnostic yield of sequencing tests, potentially providing …

Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases

EL Salfati, EG Spencer, SE Topol, ED Muse, M Rueda… - Genome medicine, 2019 - Springer
Background Whole-exome sequencing (WES) has become an efficient diagnostic test for
patients with likely monogenic conditions such as rare idiopathic diseases or sudden …